Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00215696
Status:
COMPLETED
Last Update Posted:
2011-05-13
First Post:
2005-09-15
Brief Title:
A Study to Treat Patients Whose Chronic Angina Symptoms Are Not Relieved by Medication and Have an Area of the Heart That Cannot be Treated by Standard Therapies
Sponsor:
GenVec
Organization:
GenVec
Study Overview
Official Title:
A Multicenter Randomized Double-Blind Placebo-Controlled Study Evaluating the Efficacy of BIOBYPASS ADGVVEGF12110NH Delivered by NOGA-GUIDEDMYOSTAR Catheter in No Option Patients With Class II-IV Stable Angina
Status:
COMPLETED
Status Verified Date:
2011-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary purpose of this study is to determine whether treatment with an experimental gene therapy BIOBYPASS will reduce angina in study participants by stimulating the growth of new blood vessels This will be measured by testing whether participants are able to exercise longer without experiencing angina after treatment as compared to before treatment
Additionally this study will collect information about any side effects that might be related to the treatment with the experimental therapy
Additionally this study will collect information about any side effects that might be related to the treatment with the experimental therapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None